News 10/06/2014

As Culture Changed, So Did Melanoma Risk, Study Finds

Changing fashions, cultural attitudes and health beliefs have contributed to the rise of deadly melanoma skin cancer, according to a new study.

News 09/16/2014

Health Canada Approves Yervoy® (Ipilimumab) For First-line Treatment of Adults With Metastatic Melanoma, the Most Deadly Form of Skin Cancer

Bristol-Myers Squibb Canada is pleased to announce that Health Canada has approved Yervoy® (ipilimumab) as a first-line therapy in adults with unresectable or metastatic melanoma, the most deadly form of skin cancer. This means that Canadians with newly diagnosed advanced melanoma, regardless of the subtype, will be eligible to receive the novel immunotherapy as their initial treatment.

News 09/08/2014

Amgen Applies For EU Approval of New Melanoma Drug

Amgen has applied for European Medicines Agency approval of an investigational oncolytic immunotherapy for the treatment of regionally or distantly metastatic melanoma.

News 09/07/2014

JAMA Dermatology Authors Seek Policy Change in Melanoma Screening in US

Writers in the recent issue of JAMA Dermatology call on the healthcare system to change the way  the nation screens for melanoma, citing the $291 million annual cost of treating the disease and the $2.85 billion costs in lost productivity, which authors say could be trimmed if cases were caught earlier.

Patient, Tumor Characteristics for High-Mitotic Rate Melanoma
News 08/20/2014

Patient, Tumor Characteristics for High-Mitotic Rate Melanoma

A study in Australia examined patient and tumor characteristics for melanomas with higher mitotic rates (a marker of tumor cell growth) in an effort to increase earlier detection of this aggressive cancer in patients. August 20, 2014

New Melanomas Difficult to Detect in Patients Treated With BRAF Inhibitors
News 08/04/2014

New Melanomas Difficult to Detect in Patients Treated With BRAF Inhibitors

Patients taking a BRAF inhibitor are more susceptible to highly volatile melanocytic lesions that make the detection of new primary melanomas more difficult, according to results shared in a research letter published in JAMA: Dermatology. August 4, 2014

Please keep me informed.

Receive comprehensive, breaking news about melanoma, research, legislation, and events.

  • This field is for validation purposes and should be left unchanged.